Terms: = Kidney tumors AND RUNX1, PEBP2A2, 861, ENSG00000159216, Q01196, AML1, CBFA2, AMLCR1 AND Clinical Outcome
2 results:
1. Tumor-Stroma Proportion to Predict Chemoresistance in Patients With Ovarian Cancer.
Lou E; Clemente V; Grube M; Svedbom A; Nelson AC; Blome F; Staebler A; Kommoss S; Bazzaro M
JAMA Netw Open; 2024 Feb; 7(2):e240407. PubMed ID: 38411963
[TBL] [Abstract] [Full Text] [Related]
2. runx1 Is a Driver of Renal Cell Carcinoma Correlating with clinical outcome.
Rooney N; Mason SM; McDonald L; Däbritz JHM; Campbell KJ; Hedley A; Howard S; Athineos D; Nixon C; Clark W; Leach JDG; Sansom OJ; Edwards J; Cameron ER; Blyth K
Cancer Res; 2020 Jun; 80(11):2325-2339. PubMed ID: 32156779
[TBL] [Abstract] [Full Text] [Related]
